COVID-19 Induced Telogen Effluvium

• Conditions: Alopecia; Covid19; Telogen Effluvium; SARS-CoV Infection

• Registration Number: NCT04834102
• Lead Sponsor: Istanbul Medeniyet University

Brief Summary

This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Detailed Description

Telogen effluvium (TE) is one of the most common causes of non-scarring alopecia. During the COVİD-19 pandemic, there is an increased number of Telogen effluvium patients.This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection and correlation between the severity of covid-19 and TE.

Study Timeline

• Study Start: 2021-01-27
• Status Verified: 2021-04
• Study First Submitted: 2021-04-04
• Study First Submitted QC: 2021-04-04
• Last Update Submitted: 2021-04-04
• Study First Posted: 2021-04-06
• Last Update Posted: 2021-04-06
• Primary Completion: 2021-04-27
• Study Completion: 2021-04-27

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Sars-CoV-2 infection in the past year

Exclusion Criteria

• Other common causes of Telogen effluvium ( such as anemia, iron deficiency, thyroid dysfunction)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hair shedding	3 months	Physical examination of hair and scalp, trichoscopy, hair pull test

Trial Locations

Locations (1)

Istanbul Medeniyet University; 🇹🇷 Istanbul, Kadıköy, Turkey